Key Capital Management, INC
Position in EXEL — Exelixis, Inc.
CIK 2107249
HENDERSONVILLE, TN 37075, TN
Position in EXEL
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,666
New position
Shares Held
49
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#707
of 751 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Key Capital Management, INC holds $17,097 across 7 Biotechnology names. EXEL ranks #4 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
43 | $4,874 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6 | $2,980 | |
| 3 | RPRX |
Royalty Pharma plc
|
53 | $2,971 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
49 | $2,666 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
24 | $2,284 | |
| 6 | MRNA |
Moderna, Inc.
|
15 | $1,050 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
5 | $272 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,666 | 49 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||